These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9549422

  • 1. Treatment of deep venous thrombosis with low molecular weight heparins.
    Ruiz F, Berman D.
    West J Med; 1998 Mar; 168(3):186-7. PubMed ID: 9549422
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN.
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [Abstract] [Full Text] [Related]

  • 3. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D.
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun 12; 145(24):56. PubMed ID: 12866309
    [No Abstract] [Full Text] [Related]

  • 6. [Resource-saving treatment of deep venous thrombosis with low molecular weight heparin--but is it good enough?].
    Arnesen H.
    Tidsskr Nor Laegeforen; 1991 Nov 10; 111(27):3266-7. PubMed ID: 1659750
    [No Abstract] [Full Text] [Related]

  • 7. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK.
    Pharmacotherapy; 1998 Nov 10; 18(4):748-58. PubMed ID: 9692649
    [Abstract] [Full Text] [Related]

  • 8. Low molecular weight heparins for DVT.
    Ebell MH.
    J Fam Pract; 1994 Nov 10; 39(5):501-2. PubMed ID: 7964550
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-molecular-weight heparins. Is smaller better?
    Triplett DA.
    Arch Intern Med; 1993 Jul 12; 153(13):1525-6. PubMed ID: 8391791
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Axillary venous thrombosis (Paget-Schroetter syndrome): possible therapy by low-molecular weight heparin.
    Svarc M, Zádník J, Krc I.
    Acta Univ Palacki Olomuc Fac Med; 1993 Jul 12; 136():29-31. PubMed ID: 7887196
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
    Forbes CD.
    Br J Clin Pract; 1989 Nov 12; 43(11):396-400. PubMed ID: 2558702
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low molecular weight heparins in clinical practice: unsolved or partially solved problems.
    Girolami A.
    Arch Inst Cardiol Mex; 1998 Nov 12; 68(1):69-76. PubMed ID: 9656086
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparins allow selected outpatient treatment for venous thrombosis.
    Veller M, Louridas G, Levien L.
    S Afr Med J; 1998 Jun 12; 88(6):694-5. PubMed ID: 9687845
    [No Abstract] [Full Text] [Related]

  • 18. [The future of low molecular weight heparins in the curative treatment of deep venous thrombosis].
    St-Louis J, St-Louis JM.
    Union Med Can; 1994 Mar 12; 123(3):147-51. PubMed ID: 8184510
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparin for deep venous thrombosis.
    Bielanski TE.
    J Fam Pract; 1999 Sep 12; 48(9):661-2. PubMed ID: 10498065
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.